Anteris Technologies Global Corp. (AVR) vs Collegium Pharmaceutical, Inc. (COLL)
A side-by-side comparison of Anteris Technologies Global Corp. and Collegium Pharmaceutical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.18HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
COLL
Collegium Pharmaceutical, Inc.
$21.92HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — AVR vs COLL
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)COLL -27.3% (-14.7%/yr)AVR compounded faster over this window
AVR COLL
AVR vs COLL: by the numbers
- •COLL is the larger company ($711M vs $698M market cap).
- •COLL is profitable (5.93% net margin) while AVR runs a net loss (-4619.67%).
- •COLL grew revenue faster over the past five years (19.91% vs -18.92% CAGR).
Metrics side by side
Valuation
| Metric | AVR | COLL |
|---|---|---|
| P/E ratio | N/A | 17.68 |
| PEG ratio | N/A | 0.99 |
| P/S ratio | 311.39 | 0.88 |
| P/B ratio | 2.78 | 2.28 |
| EV / EBITDA | N/A | 2.85 |
| FCF yield | N/A | 46.17% |
Profitability
| Metric | AVR | COLL |
|---|---|---|
| Gross margin | -16.57% | 60.02% |
| Operating margin | -4908.21% | 19.61% |
| Net margin | -4619.67% | 5.93% |
| ROE | -41.20% | 15.36% |
| ROIC | -41.63% | 6.11% |
Growth (annualized)
| Metric | AVR | COLL |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | 19.91% |
| EPS CAGR (5Y) | N/A | 20.48% |
| FCF CAGR (5Y) | N/A | 26.38% |
| Total return CAGR (5Y) | N/A | 2.15% |
Frequently asked
- Which has grown faster, AVR or COLL?
- Over the past five years, COLL grew revenue faster — AVR at a -18.92% CAGR versus COLL at 19.91%.
- Is AVR or COLL more profitable?
- COLL runs the higher net margin — AVR at -4619.67% versus COLL at 5.93%.
Go deeper
Dig into the metrics
Collegium Pharmaceutical P/E ratioAnteris Technologies Global ROECollegium Pharmaceutical ROEAnteris Technologies Global operating marginCollegium Pharmaceutical operating marginAnteris Technologies Global revenue growthCollegium Pharmaceutical revenue growthAnteris Technologies Global free cash flowCollegium Pharmaceutical free cash flow
Anteris Technologies Global & Collegium Pharmaceutical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.